allogeneic - International Pharmaceutical Industry

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Volume 15 Issue 2

Gene Edited iPSCs May Find a Place in Allogeneic Therapies

An Introduction to Pluripotency Pluripotent: adjective; capable of giving rise to many different cell types. This is the hallmark characteristic of the induced pl...

3 July 2023 Volume 15 Issue 2 allogeneic | cell

Continue Reading →

News

TiGenix announces approval of trade name for lead development candidate Cx601 in Europe

TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-...